Cleared Traditional

K861374 - SUPERMON NON-INVASIVE BLOOD PRESSURE MO...

K861374 is an FDA 510(k) clearance for SUPERMON NON-INVASIVE BLOOD PRESSURE MO..., manufactured by Kontron Instruments, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 466-day FDA review.

K861374 · Kontron Instruments, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1987
Decision
466d
Days
Class 2
Risk

K861374 is an FDA 510(k) clearance for the SUPERMON NON-INVASIVE BLOOD PRESSURE MODULE 7282. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Kontron Instruments, Inc. (Everett, US). The FDA issued a Cleared decision on July 21, 1987 after a review of 466 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Kontron Instruments, Inc. devices

FDA 510(k) Submission Details - K861374

510(k) Number K861374 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 11, 1986
Decision Date July 21, 1987
Days to Decision 466 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
341d slower than avg
Panel avg: 125d · This submission: 466d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 554
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K861374.
TAKEDA MEDICAL DIGITAL SPHYGMOMANOMETER/ UA-741
K872629 · A&D Engineering, Inc. · Sep 1987
VITALNET(TM) SYSTEM (DINAMAP(TM), MODEL 2200)
K871418 · Critikon Company, LLC · Jul 1987
MODIFIED SPHYGMOMED NON-INVASIVE BLOOD PRES. MONIT
K871886 · Draeger Medical, Inc. · Jul 1987
DORROS(TM) SMALL VESSEL PTA CATHETER
K870460 · C.R. Bard, Inc. · Jun 1987
MODEL 420 SYSTEM MEASUREMENT, BLOOD PRESSURE
K871363 · Quinton, Inc. · Jun 1987
MODIFIED MODEL UA-751 DIGITAL SPHYGMONOMETER
K871719 · A&D Engineering, Inc. · Jun 1987